The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes

A crossover study

T. Sathyapalan, J. Shepherd, Stephen Atkin, E. S. Kilpatrick

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The pleiotropic effect of statins may be mediated in part through raising 25 hydroxy vitamin D (25OHD) concentrations. It has also been shown that an increase in oxidative stress and inflammatory markers are a feature of the patients with type 2 diabetes (T2DM). A cross-over study of 26 patients with T2DM taking either simvastatin 40mg or atorvastatin 10mg was undertaken. After 3months on one statin, lipids, C-reactive protein (hsCRP), 25OHD and malondialdehyde (MDA) were measured repeatedly. The same procedure was then followed taking the other statin. Despite similar lipid-lowering, the mean 25OHD was higher on atorvastatin compared with simvastatin and the mean MDA and hsCRP levels lower, irrespective of which statin the patients were taking before crossover. The changes in 25OHD predicted changes in CRP and MDA levels. Thus, compared with simvastatin, atorvastatin shows apparently beneficial pleiotropic effects with respect to 25OHD concentrations as well as markers of oxidative stress and inflammation in patients with T2DM.

Original languageEnglish
Pages (from-to)767-769
Number of pages3
JournalDiabetes, Obesity and Metabolism
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin
Vitamin D
Cross-Over Studies
Type 2 Diabetes Mellitus
Oxidative Stress
Malondialdehyde
Lipids
C-Reactive Protein
Inflammation
Atorvastatin Calcium

Keywords

  • Lipid-lowering therapy
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes : A crossover study. / Sathyapalan, T.; Shepherd, J.; Atkin, Stephen; Kilpatrick, E. S.

In: Diabetes, Obesity and Metabolism, Vol. 15, No. 8, 08.2013, p. 767-769.

Research output: Contribution to journalArticle

@article{ef60ed5ab42248c8858901e749e91f04,
title = "The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: A crossover study",
abstract = "The pleiotropic effect of statins may be mediated in part through raising 25 hydroxy vitamin D (25OHD) concentrations. It has also been shown that an increase in oxidative stress and inflammatory markers are a feature of the patients with type 2 diabetes (T2DM). A cross-over study of 26 patients with T2DM taking either simvastatin 40mg or atorvastatin 10mg was undertaken. After 3months on one statin, lipids, C-reactive protein (hsCRP), 25OHD and malondialdehyde (MDA) were measured repeatedly. The same procedure was then followed taking the other statin. Despite similar lipid-lowering, the mean 25OHD was higher on atorvastatin compared with simvastatin and the mean MDA and hsCRP levels lower, irrespective of which statin the patients were taking before crossover. The changes in 25OHD predicted changes in CRP and MDA levels. Thus, compared with simvastatin, atorvastatin shows apparently beneficial pleiotropic effects with respect to 25OHD concentrations as well as markers of oxidative stress and inflammation in patients with T2DM.",
keywords = "Lipid-lowering therapy, Type 2 diabetes",
author = "T. Sathyapalan and J. Shepherd and Stephen Atkin and Kilpatrick, {E. S.}",
year = "2013",
month = "8",
doi = "10.1111/dom.12074",
language = "English",
volume = "15",
pages = "767--769",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes

T2 - A crossover study

AU - Sathyapalan, T.

AU - Shepherd, J.

AU - Atkin, Stephen

AU - Kilpatrick, E. S.

PY - 2013/8

Y1 - 2013/8

N2 - The pleiotropic effect of statins may be mediated in part through raising 25 hydroxy vitamin D (25OHD) concentrations. It has also been shown that an increase in oxidative stress and inflammatory markers are a feature of the patients with type 2 diabetes (T2DM). A cross-over study of 26 patients with T2DM taking either simvastatin 40mg or atorvastatin 10mg was undertaken. After 3months on one statin, lipids, C-reactive protein (hsCRP), 25OHD and malondialdehyde (MDA) were measured repeatedly. The same procedure was then followed taking the other statin. Despite similar lipid-lowering, the mean 25OHD was higher on atorvastatin compared with simvastatin and the mean MDA and hsCRP levels lower, irrespective of which statin the patients were taking before crossover. The changes in 25OHD predicted changes in CRP and MDA levels. Thus, compared with simvastatin, atorvastatin shows apparently beneficial pleiotropic effects with respect to 25OHD concentrations as well as markers of oxidative stress and inflammation in patients with T2DM.

AB - The pleiotropic effect of statins may be mediated in part through raising 25 hydroxy vitamin D (25OHD) concentrations. It has also been shown that an increase in oxidative stress and inflammatory markers are a feature of the patients with type 2 diabetes (T2DM). A cross-over study of 26 patients with T2DM taking either simvastatin 40mg or atorvastatin 10mg was undertaken. After 3months on one statin, lipids, C-reactive protein (hsCRP), 25OHD and malondialdehyde (MDA) were measured repeatedly. The same procedure was then followed taking the other statin. Despite similar lipid-lowering, the mean 25OHD was higher on atorvastatin compared with simvastatin and the mean MDA and hsCRP levels lower, irrespective of which statin the patients were taking before crossover. The changes in 25OHD predicted changes in CRP and MDA levels. Thus, compared with simvastatin, atorvastatin shows apparently beneficial pleiotropic effects with respect to 25OHD concentrations as well as markers of oxidative stress and inflammation in patients with T2DM.

KW - Lipid-lowering therapy

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84879795780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879795780&partnerID=8YFLogxK

U2 - 10.1111/dom.12074

DO - 10.1111/dom.12074

M3 - Article

VL - 15

SP - 767

EP - 769

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 8

ER -